Navigation Links
Skin Animation Highlights New Dermatological Formula That Targets Psoriasis
Date:9/23/2011

ORMOND BEACH, Fla., Sept. 23, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a skin animation video depicting the positive effects of its new ExtremeSkinCare Intense Treatment Balm on skin affected with psoriasis.

View the animation here: Psoriasis treatment

The powerful, dermatological formula combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. It helps reduce the unsightly appearance of psoriasis by reducing inflammation, redness and clearing affected skin of plaques without steroids.

  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology, LLC, an R&D-based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit http://skinhealthtech.com.  

Contact:

Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or jes@skinhealthtech.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution'/>"/>

SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting
2. Elsevier Announces 2010 Journal Impact Factor Highlights
3. BioSpace Highlights the Mid-Atlantics Life Sciences Region
4. Anadys Highlights ANA773 Data to be Presented at ASCO
5. Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights
6. InterMune Reports First Quarter 2011 Financial Results and Business Highlights
7. BioSpace Highlights North Carolinas Life Science Regions
8. Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments
9. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights
10. Tech Coast Angels Funds 31 Deals in 2010 and Highlights Three Profitable Exits
11. Webcast Alert: Isis Pharmaceuticals 2010 Financial Results and Highlights Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Market by Product (1D & 2D Gel Electrophoresis, Agarose ... CGE, MEKC, Reagents, Informatics), by Application & by End ... the Electrophoresis Market is expected to reach around $1.98 ... the forecast period 2015 to 2020. ...
(Date:5/22/2015)... May 22, 2015 Knowledgent , ... paper that explores the potential of big data analytics ... paper was developed to help life sciences and healthcare ... data to gain critical business insights. , The life ... of data driven by patient profiling, compliance and regulatory ...
(Date:5/21/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... second fiscal quarter ended March 31, 2015. ... business with our existing customers and to develop new ... of SQI. "The delivery of a fully automated sqidlite™ ...
(Date:5/21/2015)... N.J. (PRWEB) May 21, 2015 ... circulation audit and been admitted to BPA Worldwide ... BPA Worldwide will track audience data for Specialty ... coverage. , “By becoming a member of ... dedication to providing our clients with the most ...
Breaking Biology Technology:Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Specialty Pharmacy Times Joins BPA Worldwide 2
... Governor Jim Doyle and former Governor Tommy Thompson rarely ... of electronic health records, however, Doyle and Thompson are ... state budget includes $10 million in grants and loans ... records, a move that could help harness the power ...
... announcement out of Kings College London that Professor ... a license by the British government to clone human embryos ... and advocacy groups for a cure to such diseases as ... be addressed through research on stem cells, which Wilmut will ...
... Invitrogen : 4,000 employees worldwide. Headquartered in Carlsbad, California. ... America, 65 in Brown Deer. Headquartered in Oslo, Norway. ... Corp. plans to acquire Dynal Biotech ASA ... Wisconsin, by the end of March for $380.4 million. ...
Cached Biology Technology:Electronic health records can save lives and improve medical care 2Electronic health records can save lives and improve medical care 3Human cloning plans get blessing from British government 2Human cloning plans get blessing from British government 3Invitrogen to buy Norwegian biotech with operations in Brown Deer 2
(Date:5/18/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... In an advance that could help ease health ... are reporting development of technology for changing the behavior ... main gateway into the environment. Their study will be ... Science & Technology . Helen Jarvie from ...
... A free, day-long terrorism preparedness symposium covering counter-terrorist strategies ... and regional concerns will be held at NJIT on ... The event sponsor, the New Jersey Chapter of ... national groups to brief participants on topics ranging from ...
... "chocolate cure" for emotional stress is getting new support ... Journal of Proteome Research . It found that eating ... a day for two weeks reduced levels of stress ... Everyone,s favorite treat also partially corrected other stress-related biochemical ...
Cached Biology News:Behavior modification could ease concerns about nanoparticles 2
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
Tropomyosin 4 [Tm4]...
Phospho-MEF2A(Thr312)...
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Biology Products: